40% of the prescription last quarter were written in two largest dialysis center in the country which is not captured by IMS or Symphony. so if you divide 354 by .6 to get to real number, that will be 590 total prescription for past week. I think we are getting there. We also have very strong catalysts on the way, European partnership, and test results for label expansion.
The real issue stems from a new excuse the manged have come up with to not pay for proscriptions written by Doctors.In last few years if the drugs are available over the counter. Many powerful generic prescription drugs have found their way into the over the counter, these over the counter drugs in most cases sell for higher price than the same thing if you could buy them with prescription as generic. If cost you a lot less to buy generic Omprazole ( Prilozac) in generic prescription than buying it over the counter.
In the case of Horizon, company would probably be willing to sell the drug for less than over the counter cost of the combo drugs, but that is not good enough for insurance companies, they do not want to pay any, they want patients to foot the whole bill and buy the components over the counter. Horizon would probably have very successful drug for selling it's drug through insurance at a very reasonable price , that because the drugs are really very good and would be used very widespread. Horizon's average selling price is much less, that because they average a lot of zero pay with the high price that get paid. I think at the end, this will come down to, do the insurance company have the right to refuse to pay for a drug that the doctors have written prescription for, and it is very beneficial, and saves lives and ask the patients to go over the counter and buy the components, I side against the insurance companies on this. Horizon's hands were forced to be creative when E. Scripts decided they do not want to pay for a reasonably priced drug that would be beneficial to patients, The extreme case of E. Scripts argument would be to ask patient to go on and make his own drug if ingredients are available on the market.
So, they had 312 average prescriptions on the quarter just reported, this is much better than we were getting from IMS. On the conference call it was said that Davita and others are not reported by the IMS. Revenue increased 88% sequentially, this is not bad.
Does anyone have the script numbers from last friday
This is very good, it shows 1000 refill, almost 3 times new scripts. Are they counting the scripts after the samples a refill or new script?
How do you reach that conclusion, 1540 for july translates to over 31 per day, that is over 350 weekly, which is against 250 of IMS. You need to go back to elementary school.
Fire the incompetent two and get someone that knows how to get this off the ground. Obviously the sales force is barking at the wrong tree, the strategy needs to change. Maybe lshould lower the damn price, get the insurance companies on board, get market share and then raise the price later. Do something dumb numbs. When you call the company, you cannot even get the switch board online, what is switchboard doing out to lunch with sales manager?
If IMS numbers show any sign that drug is starting to sell, KERX will have a huge short covering.
Call your broker and tell them you want your KERX shares to be moved from margin to cash account, this by should create a short squeez.